Dr Mark Bloch

Gates TM; Kamminga J; Jayewardene A; Vincent T; Quan D; Brew BJ; Bloch M; Cysique LA, 2021, 'An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications', Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 36, pp. 597 - 612, http://dx.doi.org/10.1093/arclin/acaa076

Aung HL; Bloch M; Vincent T; Quan D; Jayewardene A; Liu Z; Gates TM; Brew B; Mao L; Cysique LA, 2021, 'Cognitive ageing is premature among a community sample of optimally treated people living with HIV', HIV Medicine, vol. 22, pp. 151 - 164, http://dx.doi.org/10.1111/hiv.12980

Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton D; Zablotska-Manos I; Hoy J; McNulty A; Pell C; Grulich A; Bavinton B; Zablotska IB; Grinsztejn B; Cooper DA; Emery S; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2021, 'Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand', AIDS and Behavior, http://dx.doi.org/10.1007/s10461-021-03324-7

Bloch M, 2020, 'Prescribing pre-exposure prophylaxis for HIV', Australian Prescriber, vol. 43, pp. 200 - 203, http://dx.doi.org/10.18773/austprescr.2020.057

Vourli G; Noori T; Pharris A; Porter K; Axelsson M; Begovac J; Cazein F; Costagliola D; Cowan S; Croxford S; Monforte ADA; Delpech V; Díaz A; Girardi E; Gunsenheimer-Bartmeyer B; Hernando V; Leierer G; Lot F; Nunez O; Obel N; Op de Coul E; Paraskeva D; Patrinos S; Reiss P; Schmid D; Sonnerborg A; Suligoi B; Supervie V; van Sighem A; Zangerle R; Touloumi G; Egle A; Kanatschnig M; Öllinger A; Rieger A; Schmied B; Wallner E; Dewasurendra D; Gisinger M; Kitchen M; Plattner A; Rieser E; Sarcletti M; Greil R; Schachner M; Skocic M; Müller M; Aichwalder R; Chromy D; Grabmeier-Pfstershammer K; Skoll M; Touzeau V; Cichon P; Wolf-Nussmüller S; Laferl H; Zoufaly A; Genger-Hackl C; Kapper A; Schneeberger T; Trattner E; Schober G; Atzl M; Hartmann B; Puchhammer-Stöckl E; Berg J; Appoyer H; Rappold M; Strickner S; Schindelwig K; Ledergerber B; Fätkenheuer G; Gerstof J; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Mohey R; Nielsen L; Weise L; Kvinesdal B; Jensen J; Abgrall S; Bernard L; Billaud E; Boué F; Boyer L; Cabié A; Caby F; Canestri A; Cotte L; de Truchis P; Duval X; Duvivier C; Enel P; Fischer H; Gasnault J; Gaud C; Grabar S; Khuong-Josses MA; Launay O, 2020, 'Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?', Clinical Infectious Diseases, vol. 71, pp. 2905 - 2916, http://dx.doi.org/10.1093/cid/ciaa696

Bloch M; John M; Smith D; Rasmussen TA; Wright E, 2020, 'Managing HIV-associated inflammation and ageing in the era of modern ART', HIV Medicine, vol. 21, pp. 2 - 16, http://dx.doi.org/10.1111/hiv.12952

Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, vol. 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985

Heron JE; Bloch M; Vanguru V; Saunders J; Gracey DM, 2020, 'Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: A case report', BMC Nephrology, vol. 21, pp. 339, http://dx.doi.org/10.1186/s12882-020-01981-9

Boccara F; Kumar PN; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS; Baker D; Bloch M; Finlayson R; Hoy J; Koh K; Roth N; De Wit S; Florence E; Vandekerckhove L; Ramalho Madruga JV; Wagner Cardoso S; Bondy G; Gill M; Tsoukas G; Trottier S; Smieja M; Katlama C; Bonnet F; Raffi F; Cotte L; Molina JM; Reynes J; Papadopoulos A; Metallidis S; Paparizos V; Papastamopoulos V; Mussini C; Galli M; Antinori A; Di Biagio A; Viale P; Horban A; Marques N; Coutinho D; Oliveira J; Freitas P; Preotescu LL; Marincu I; Silaghi R; Rugina S; Mwelase N; Kotze S; Bernardino de la Serna JI; Estrada Perez V; Martinez E; Curran A; Braun DL; Bernasconi E; Cavassini M; Walsh J; Fox J; Moyle G; Rosenson R; Morano J; Baker J; Pierone G; Fichtenbaum C; Benson P; Goldstein D; Sacco J; Kumar P; Grossberg R; Chew K; DeFilippi C; Drelichman V; Markowitz N; Parenti D; Doktor K; Thompson P, 2020, 'Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study', Journal of the American College of Cardiology, vol. 75, pp. 2570 - 2584, http://dx.doi.org/10.1016/j.jacc.2020.03.025

Carr M; Richardson R; Tong W; Bloch M; Baker D; Hoy JF, 2020, 'Switch from tenofovir disoproxil fumarate to raltegravir is not associated with weight gain over 96 weeks', AIDS, vol. 34, pp. 789 - 790, http://dx.doi.org/10.1097/QAD.0000000000002473

Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV, 2020, 'Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV', AIDS, vol. 34, pp. 1347 - 1358, http://dx.doi.org/10.1097/QAD.0000000000002562

Molina JM; Squires K; Sax PE; Cahn P; Lombaard J; DeJesus E; Lai MT; Rodgers A; Lupinacci L; Kumar S; Sklar P; Hanna GJ; Hwang C; Martin EA; Hagins DP; Osiyemi OO; Prelutsky DJ; Ramgopal MN; Scarsella AJ; Dretler R; Bettacchi CJ; Sims J; Clay PG; Bellos NC; Thompson MA; Montero J; McDonald CK; Creticos C; Shamblaw D; Mogyoros M; Terrelonge AE; Valdes M; Tashima KT; Robbins WJ; Felizarta FA; Elion RA; Slim J; Win SS; Lalla-Reddy SN; Ruane PJ; Mills A; Cade JL; Dietz CA; Rubin DS; Mayer C; Rondon JC; Cook PP; Daar E; Kumar PN; Swindells S; Castro JG; Melendez-Rivera I; Morales-Ramirez JO; Santiago L; Santana-Bagur JL; Martins M; Cahn PE; Lopardo GD; Porteiro N; Bloch MT; Baker DA; Roth N; Moore RJ; Finlayson RJ; McMahon J; Rieger A; Zoufaly A; Hartl S; Zangerle R; Smaill F; Walmsley SL; Conway B; Rachlis A; Smith GHR; Perez C; Afani A; Campos MI; Chahin CE; Wolff Reyes M; Gerstoft J; Weis N; Laursen AL; Yazdanpanah Y; Cotte L; Raffi F; Morlat P; Girard PM; Katlama C; Rockstroh JK; Arasteh K; Esser S; Stoehr A; Stellbrink HJ; Stoll M; Schuermann D; Faetkenheuer G; Bogner J; Lutz T; Baumgarten A; Jaeger H, 2020, 'Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial', The Lancet HIV, vol. 7, pp. e16 - e26, http://dx.doi.org/10.1016/S2352-3018(19)30336-4

Zablotska IB; Vaccher SJ; Bloch M; Carr A; Foster R; Grulich AE; Guy R; McNulty A; Ooi C; Pell C; Poynten IM; Prestage G; Ryder N; Templeton D; Cheung C; Gianacas C; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; de Wit J; Wright E, 2019, 'High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE', AIDS and Behavior, vol. 23, pp. 1780 - 1789, http://dx.doi.org/10.1007/s10461-018-2290-3

Brazier E; Maruri F; Duda SN; Tymejczyk O; Wester CW; Somi G; Ross J; Freeman A; Cornell M; Poda A; Musick BS; Zhang F; Althoff KN; Mugglin C; Kimmel AD; Yotebieng M; Nash D; Karminia A; Sohn AH; Allen D; Bloch M; Boyd S; Brown K; Costa J; Donohue W; Gunathilake M; Hoy J; MacRae K; Moore R; Roth N; Rowling D; Silvers J; Smith DJ; Sowden D; Templeton D; Varma R; Woolley I; Youds D; Chhay Meng S; Vannary B; Chan YT; Lam W; Lee MP; Ning H; Pansy YPC; Kumarasamy N; Pujari S; Kurniati N; Merati TP; Muktiarti D; Parwata WS; Ratni M; Sukmawati NMDD; Vedaswari DSPD; Wati KDK; Yunihastuty E; Tanuma J; Mills G; Raymond N; Ditangco R; Papa OS; Oon Tek N; Ah-neez ; Azwa R; Dato ; Daud F; Juin WK; Kamarulzaman AB; Khairulddin N; Li CM; Moy FS; Shah RI; Shyan WP; Sim B; Thahira JM; Tuang KM; Yusoff N; Choi JY; Chan YJ; Huang CS; Wing-Wai W; Avihingsanon A; Chokephaibulkit K; Hansudewechakul R; Khumcha B; Khusuwan S; Kiertiburanakul S; Lumbiganon P; Maleesatharn A; Praparattanapan J; Puthanakit T; Sricharoenchai S; Sudjaritruk T; Watanaporn S; Thien An V; Cuong DD; Hằng BT; Huy BVŨ; Quy DT; Van LN, 2019, 'Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey', Journal of the International AIDS Society, vol. 22, http://dx.doi.org/10.1002/jia2.25331

Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE, 2019, 'Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries', Journal of the International AIDS Society, vol. 22, pp. e25277, http://dx.doi.org/10.1002/jia2.25277

Puhr R; Petoumenos K; Huang R; Templeton DJ; Woolley I; Bloch M; Russell D; Law MG; Cooper DA, 2019, 'Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study', HIV Medicine, vol. 20, pp. 121 - 130, http://dx.doi.org/10.1111/hiv.12689

Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K; Cassetti L; David D; Figueras L; Losso M; Lopardo G; Lupo S; Porteiro N; Sánchez M; Bloch M; Cooper D; Finlayson R; Kelleher A; Koh K; Lewis D; McMahon J; Moore R; Roth N; Shields M; De Wit S; Florence E; Goffard JC; Demeester R; Lacor P; Vandercam B; Vandekerckhove L; Angel J; Baril JG; Conway B; De Pokomandy A; Szabo J; Walmsley S; Bouchaud O; Chidiac C; Delobel P; Goujard C; Katlama C; Molina JM; Pialoux G; Philibert P; Bogner J; Esser S; Krznaric I; Lehmann C; Spinner C; Stellbrink HJ; Stephan C; Stoehr A; Barchi E; Caramello P; Castelli F; Cattelan AM; D'Arminio Monforte A; Di Biagio A; Di Perri G; Gori A; Maggiolo F; Menzaghi B; Migliorino G; Mussini C; Penco G; Puoti M; Rizzardini G; Gulminetti R; Lazzarin A; Quirino T; Sighinolfi L; Viale P; Amaya Tapia G; Andrade Villanueva J; Granados Reyes ER; Perez Rios A; Santoscoy Gomez M; Den Hollander J; Rijnders B; Hidalgo JA; Hercilla Vasquez L; Illescas L; Olczak A; Mansinho K; Correia Pacheco PP, 2019, 'Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials', The Lancet, vol. 393, pp. 143 - 155, http://dx.doi.org/10.1016/S0140-6736(18)32462-0

Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, vol. 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9

Bloch M, 2018, 'Frailty in people living with HIV', AIDS Research and Therapy, vol. 15, http://dx.doi.org/10.1186/s12981-018-0210-2

Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HMA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA; Smith D; Ooi C; Martin S; Soo TM; Templeton D; Townson D; Forssman B; Doong N; Han Thai G; Anderson B; MacLeod H; Parkhill N, 2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, vol. 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7

Martinello M; Dore GJ; Skurowski J; Bopage RI; Finlayson R; Baker D; Bloch M; Matthews GV, 2018, 'Erratum: Antiretroviral use in the CEASE cohort study and implications for direct-acting antiviral therapy in human immunodeficiency virus/hepatitis C virus coinfection (Open Forum Infect Diss (2016)3:2(ofw105) DOI: 10.1093/ofid/ofw105)', Open Forum Infectious Diseases, vol. 5, http://dx.doi.org/10.1093/ofid/ofy033

Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore R; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE; Bas A; Cooper DA; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Templeton DJ; McNulty A; Pell C; Hoy J; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2018, 'Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study', The Lancet HIV, vol. 5, pp. e438 - e447, http://dx.doi.org/10.1016/S2352-3018(18)30132-2

Unal G; Alessandri-Gradt E; Leoz M; Pavie J; Lefèvre C; Panjo H; Charpentier C; Descamps D; Barin F; Simon F; Meyer L; Plantier JC; Chennebault J; Fialaire P; Le Guillou-Guillemette H; Rehaiem S; Chanzy B; Clavere G; Gaillat J; Courdavault L; Genet P; Gerbe J; Benoit C; Honore Bouakline S; Waldner A; Bettinger D; Chirouze C; Bernard N; Reigadas S; Dupont X; Gaillard JL; Gault E; Reimann E; Otterbein G; Thomas L; Vaghefi P; Benoit M; Buthiot N; Goux A; Chambrin V; Deback C; Fior R; Raho Moussa M; Antoniotti O; Coban D; Cormerais L; Henquell C; Jacomet C; Lesens O; Chanoine N; Villmant A; Van Autreve JL; Bloch M; Ichou H; Manceron V; Mortier E; Zeng A; Bouvier-Alias M; Dominguez S; Lascaux-Cametez AS; Lelievre JD; Levy Y; Melica-Gregoire G; Pawlotsky JM; Pothier P; Waldner A; Inchiappa L; Verhaeghe A; Olivier B; Pathe JP; Berthe H; Mathez D; Favret V; Troisvallets D; Vandemeulebroucke E; Ceccaldi J; El Harif Z; Bocket L; Barbut P; Chaix F; Lambert C; Lambolez T; Miatezila J; Son O; Brunet P; Chappe C; Dhiver C; Lecomte V; Meddeb L; Poizot-Martin I; Tamalet C; Valadier J; Beck-Wirth G; Benomar M; Delarbre JM; Peter JM; Bevilacqua S; Venard V; Daneluzzi V; Idri N, 2018, 'Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals', Clinical Infectious Diseases, vol. 66, pp. 1785 - 1793, http://dx.doi.org/10.1093/cid/cix1087

Molina JM; Squires K; Sax PE; Cahn P; Lombaard J; DeJesus E; Lai MT; Xu X; Rodgers A; Lupinacci L; Kumar S; Sklar P; Nguyen BY; Hanna GJ; Hwang C; Martins M; Cahn PE; Lopardo GD; Porteiro N; Bloch MT; Baker DA; Roth N; Moore RJ; Finlayson RJ; McMahon J; Rieger A; Zoufaly A; Hartl S; Zangerle R; Smaill F; Walmsley SL; Conway B; Rachlis A; Smith GHR; Perez C; Afani A; Campos Barker MIE; Chahin CE; Wolff Reyes M; Gerstoft J; Weis N; Laursen AL; Yazdanpanah Y; Cotte L; Raffi F; Morlat P; Girard PM; Katlama C; Rockstroh JK; Arasteh K; Esser S; Stoehr A; Stellbrink HJ; Stoll M; Schuermann D; Faetkenheuer G; Bogner J; Lutz T; Baumgarten A; Jaeger H; Gori A; Coltan G; Constandis F; Erscoiu SM; Prisacariu LJ; Rugina S; Streinu-Cercel A; Pokrovsky VV; Zakharova NV; Shuldyakov AA; Ryamova EP; Kulagin VV; Tsybakova OA; Orlova-Morozova E; Nagimova F; Voronin E; Shimonova TE; Kozyrev OA; Orrell C; Botes ME; Portilla J; Gatell JM; Perez MJ; Arribas JR; Negredo E; Podzamczer D; Pulido F; Troya J; De los Santos I; Berenguer J; Williams IG; Johnson MA; Schembri G; Clarke A; Gompels M; Fox JM; Taylor SJ; Kegg S, 2018, 'Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial', The Lancet HIV, vol. 5, pp. e211 - e220, http://dx.doi.org/10.1016/S2352-3018(18)30021-3

Ferrer PE; Bloch M; Roth N; Finlayson R; Baker D; Koh K; Orth D; Urbaityte R; Brown D; Drummond F, 2018, 'A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes', International Journal of STD and AIDS, vol. 29, pp. 300 - 305, http://dx.doi.org/10.1177/0956462417730474

Stirrup OT; Copas AJ; Phillips AN; Gill MJ; Geskus RB; Touloumi G; Young J; Bucher HC; Babiker AG; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte A; Luca A; Prins M; Geskus R; Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AM; Rosinska M; Muga R; Tor J; Olalla P; Cayla J; Moreno S; Monge S; Amo J; Romero J; Pérez-Hoyos S; Sönnerborg A; Bucher C; Günthard H; Scherrer A; Malyuta R; Murphy G; Porter K; Johnson A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Price MA; Gilmour J; Kamali A; Karita E, 2018, 'Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion', HIV Medicine, vol. 19, pp. 184 - 194, http://dx.doi.org/10.1111/hiv.12567

de Looze F; Russo M; Bloch M; Montgomery B; Shephard A; DeVito R, 2018, 'Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection', Pain management, vol. 8, pp. 79 - 83, http://dx.doi.org/10.2217/pmt-2017-0100

Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE; Parkhill N; Chant K; Cooper C; Crooks L; Allen D; Baker D; Bloch M; Bopage R; Brown K; Carr A; Carmody C; Collins K; Finlayson R; Foster R; Jackson E; Lewis D; Lusk J; O'Connor C; Ryder N; Vlahakis E; Read P; Yeung B; Levitt G; Ogilvie E; Vaccher S; Hammoud M; Watchirs-Smith L; Wabe N, 2018, 'Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial', BMC Public Health, vol. 18, http://dx.doi.org/10.1186/s12889-017-5018-9

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; De Wit J; Carr A, 2018, 'Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy', AIDS, vol. 32, pp. 35 - 48, http://dx.doi.org/10.1097/QAD.0000000000001685

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, vol. 19, pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532

Soodla P; Simmons R; Huik K; Pauskar M; Jõgeda EL; Rajasaar H; Kallaste E; Maimets M; Avi R; Murphy G; Porter K; Lutsar I; Del Amo J; Meyer L; Bucher HC; Chêne G; Hamouda O; Pillay D; Prins M; Rosinska M; Sabin C; Touloumi G; Olson A; Cartier A; Fradette L; Walker S; Babiker A; De Luca A; Fisher M; Muga R; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Boufassa F; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Tor J; de Olalla PG; Cayla J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Sönnerborg A; Günthard H; Scherrer A; Malyuta R; Johnson A; Phillips A; Morrison C; Price MA; Giaquinto C; Grarup J; Kirk O; Bailey H; Volny Anne A; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Møller C; Rakhmanova A; Rockstroh J, 2018, 'HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay', HIV Medicine, vol. 19, pp. 33 - 41, http://dx.doi.org/10.1111/hiv.12535

Bruneel F; Tubach F; Mira JP; Houze S; Gibot S; Huisse MG; Megarbane B; Choquet C; Corne P; Peytel E; Villers D; Camus C; Bouchaud O; Caumes E; Girard PM; Simon F; Kalloumeh A; Roy C; Durand R; Le Bras J; Matheron S; Wolff M; Mourvillier B; Aubron C; Bouadma L; Regnier B; d’Ortenzio E; Matra R; Bouvet E; Tourret J; Dorchies J; Males S; Rioux C; Flicoteaux R; Yeni P; Spingler F; Kargougou E; Casalino E; Ollivier V; Grandchamp B; Miri Y; Fresnoy E; Grelon F; Asfar P; Kouatchet A; Mercat A; Joly-Guillou ML; Kempf M; Eveillard M; Daoudal P; Royer A; Runge I; Mathonnet A; Boulain T; Bret L; Hocqueloux L; Segalin JM; Mille C; Niang M; Prazuck T; Fortin M; Schortgen F; Brun Buisson C; Botterel F; Bretagne S; Leroy O; Georges H; Meybeck A; Guery B; Patoz P; Dhennain C; Chakarian D; Azougagh K; Bonmarchand G; Abboud P; Favennec L; Lemeland JF; Petrognani R; Nau A; Puidupin A; Carpentier JP; Garnotel E; Moalic JL; Tual L; Amathieu R; Dhonneur G; N’Diaye M; Jeantils V; Chassaignon C; Guillerm AL; Riche D; Javaud N; Pevirieri F; Benkel J; Luis D; Bon MC; Lenoir G; Bernot B; Collignon A; Bemba D, 2018, 'Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study (Intensive Care Medicine, (2016), 42, 10, (1588-1596), 10.1007/s00134-016-4356-x)', Intensive Care Medicine, vol. 44, pp. 141 - 143, http://dx.doi.org/10.1007/s00134-017-4978-7

Philpot SP; Prestage G; Ellard J; Grulich AE; Bavinton BR, 2018, 'How do gay serodiscordant couples in Sydney, Australia negotiate undetectable viral load for HIV prevention?', AIDS and Behavior, vol. 22, pp. 3981 - 3990, http://dx.doi.org/10.1007/s10461-018-2247-6

Beigel JH; Bao Y; Beeler J; Manosuthi W; Slandzicki A; Dar SM; Panuto J; Beasley RL; Perez-Patrigeon S; Suwanpimolkul G; Losso MH; McClure N; Bozzolo DR; Myers C; Holley HP; Hoopes J; Lane HC; Hughes MD; Davey RT; Winnie M; Dinh DV; Seethala R; Garcia H; Pouzar J; Seep M; Riffer E; Bart B; Hoppers M; Rowe H; Wolfe C; Desantis D; Baynton B; Markowitz N; Stearns ZA; Cho J; Goisse M; Wolf TA; Kay J; Dharan N; Fitzgibbons W; Woodruff M; Bell T; Lenzmeier T; Schooley R; Elie MC; Winokur P; Finberg R; Hurt C; Tebas P; Sattler FR; Ampajwala M; Batts D; Bloch M; Moore R; Dwyer D; Romo-Garcia J; Patrigeon SP; Zulueta APR; Manosuthi W; Chetchotisakd P; Ruxrungtham K; Avihingsanon A; Ratanasuwan W; Lupo S; Trape L; Macias LM; Lopardo G; Barcelona L; Mykietuk A; Alzogaray MF, 2017, 'Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial', The Lancet Infectious Diseases, vol. 17, pp. 1255 - 1265, http://dx.doi.org/10.1016/S1473-3099(17)30476-0

Cahn P; Kaplan R; Sax PE; Squires K; Molina JM; Avihingsanon A; Ratanasuwan W; Rojas E; Rassool M; Bloch M; Vandekerckhove L; Ruane P; Yazdanpanah Y; Katlama C; Xu X; Rodgers A; East L; Wenning L; Rawlins S; Homony B; Sklar P; Nguyen BY; Leavitt R; Teppler H; Cahn PE; Cassetti I; Losso M; Bloch MT; Roth N; McMahon J; Moore RJ; Smith D; Clumeck N; Vanderkerckhove L; Vandercam B; Moutschen M; Baril J; Conway B; Smaill F; Smith GHR; Rachlis A; Walmsley SL; Perez C; Wolff M; Lasso MF; Chahin CE; Velez JD; Sussmann O; Reynes J; Katlama C; Ferret S; Durant J; Duvivier C; Poizot-Martin I; Ajana F; Rockstroh JK; Faetkanheuer G; Esser S; Jaeger H; Degen O; Bickel M; Bogner J; Arasteh K; Hartl H; Stoehr A; Arathoon E; Gonzalez LD; Mejia CR; Shahar E; Turner D; Levy I; Sthoeger Z; Elinav H; Gori A; Monforte ADA; Di Perri G; Lazzarin A; Rizzardini G; Antinori A; Celesia BM; Maggiolo F; Chow TS; Lee CKC; Azwa RISR; Mustafa M; Oyanguren M; Castillo RA; Hercilla L; Echiverri C; Maltez F; da Cunha JS; Neves I; Teofilo E; Serrao R; Nagimova F; Khaertynova I; Orlova-Morozova E; Voronin E; Sotnikov V, 2017, 'Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial', The Lancet HIV, vol. 4, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(17)30128-5

Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, vol. 18, pp. 701 - 703, http://dx.doi.org/10.1111/hiv.12504

Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wasik TJ; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Kücherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte AD; De Luca A; Prins M; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Muga R; Tor J; de Olalla PG; Cayla J; del Amo J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Bucher HC; Rickenbach M; Francioli P; Malyuta R; Murphy G; Sabin C; Porter K; Johnson A; Phillips A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Gibb D; Grarup J; Kirk O; Kjaer J; Panteleev A; Reiss P; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; De Wolf F; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Anne AV, 2017, 'HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review', AIDS Reviews, vol. 19, pp. 219 - 230

Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA, 2017, 'Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure', Journal of Clinical and Experimental Neuropsychology, vol. 39, pp. 753 - 767, http://dx.doi.org/10.1080/13803395.2016.1263282

Petoumenos K; Huang R; Hoy J; Bloch M; Templeton DJ; Baker D; Giles M; Law MG; Cooper DA, 2017, 'Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years - The Australian Positive & Peers Longevity Evaluation Study (APPLES)', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0184583

Pozniak A; Flamm J; Antinori A; Bloch M; Ward D; Berenguer J; Cote P; Andreatta K; Garner W; Szwarcberg J; Nguyen-Cleary T; McColl DJ; Piontkowsky D, 2017, 'Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI', HIV Clinical Trials, vol. 18, pp. 141 - 148, http://dx.doi.org/10.1080/15284336.2017.1338844

Hey-Nguyen WJ; Xu Y; Pearson CF; Bailey M; Suzuki K; Tantau R; Obeid S; Milner B; Field A; Carr A; Bloch M; Cooper DA; Kelleher AD; Zaunders JJ; Koelsch KK, 2017, 'Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes during Antiretroviral Therapy', AIDS Research and Human Retroviruses, vol. 33, pp. 648 - 657, http://dx.doi.org/10.1089/aid.2016.0171

Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA, 2017, 'Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use', Current HIV/AIDS Reports, vol. 14, pp. 83 - 92, http://dx.doi.org/10.1007/s11904-017-0349-9

Martinello M; Dore GJ; Bopage RI; Finlayson R; Baker D; Bloch M; Filep E; Skurowski J; Lin L; Lamoury F; Bartlett S; Applegate T; Hellard M; Matthews GV, 2017, 'O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy', Journal of Virus Eradication, vol. 3, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30890-6

Lee FJ; Monteiro P; Baker D; Bloch M; Roth N; Finlayson R; Moore R; Hoy J; Martinez E; Carr A, 2016, 'Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial', HIV Medicine, vol. 17, pp. 605 - 614, http://dx.doi.org/10.1111/hiv.12362

Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA, 2016, 'A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review', Clinical Infectious Diseases, vol. 63, pp. 687 - 693, http://dx.doi.org/10.1093/cid/ciw399

Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I; Carr A; Cheung C; Foster R; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; Murphy D; Ooi C; Pell C; Poynten M; Ryder N; De Wit J; Wright E, 2016, 'Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE', BMJ Open, vol. 6, http://dx.doi.org/10.1136/bmjopen-2016-012179

de Looze F; Russo M; Bloch M; Montgomery B; Shephard A; Smith G; Aspley S, 2016, 'Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: A randomised controlled trial', European Journal of General Practice, vol. 22, pp. 111 - 118, http://dx.doi.org/10.3109/13814788.2016.1145650

Lee FJ; Marriott D; Bloch M; Richardson R; Mackenzie N; Carr A, 2016, 'Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 1127 - 1129, http://dx.doi.org/10.1093/jac/dkv436

Martinello M; Dore GJ; Skurowski J; Bopage RI; Finlayson R; Baker D; Bloch M; Matthews GV, 2016, 'Antiretroviral use in the CEASE cohort study and implications for direct-acting antiviral therapy in human immunodeficiency virus/hepatitis C virus coinfection', Open Forum Infectious Diseases, vol. 3, http://dx.doi.org/10.1093/ofid/ofw105

Pozniak A; Arribas JR; Gathe J; Gupta SK; Post FA; Bloch M; Avihingsanon A; Crofoot G; Benson P; Lichtenstein K; Ramgopal M; Chetchotisakd P; Custodio JM; Abram ME; Wei X; Cheng A; McCallister S; SenGupta D; Fordyce MW, 2016, 'Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48-week results from a single-arm, multicenter, open-label phase 3 study', Journal of Acquired Immune Deficiency Syndromes, vol. 71, pp. 530 - 537, http://dx.doi.org/10.1097/QAI.0000000000000908

Lortholary O; Roussillon C; Boucherie C; Padoin C; Chaix ML; Breton G; Rami A; Veziris N; Patey O; Caumes E; May T; Molina JM; Robert J; Tod M; Fagard C; Chêne G; Aumaĭtre H; Borsato F; Malet M; Médus M; Moreau L; Neuville S; Saada M; Abgrall S; Ahoudji D; Balmard L; Bentata M; Bouchaud O; Boudribila A; Cailhol J; Dhote R; Djebbar R; Gros H; Honoré P; Huynh T; Krivitzky A; Mansouri R; Pizzocolo C; Rouges F; Viot E; Amar B; Bantsimba J; Dellion S; Richier L; Dupon M; Dutronc H; Neau D; Ragnaud JM; Raymond I; Boucly S; Gailhoustet L; Lortholary O; Maignan A; Touam F; Viard JP; Bergmann JF; Boulanger E; Delcey V; Diemer M; Durel A; Jouade F; Parrinello M; Sellier P; Brazille P; Leclerc C; Welker Y; Bernard L; Berthé H; Perronne C; Salomon J; De Truchis P; Bolliot C; Couzigou C; Derradji O; Escaut L; Teicher E; Vittecoq D; Chakvetadze C; Fontaine C; L'Yavanc T; Maresca A; Pialoux G; Slama L; Tuna L; Bornarel D; Boué F; Chassaing A; Chaiba-Berroukeche L; Chambrin V; Delavalle AM; Galanaud P; Levy A; Pignon C; Bonnet D; Ecobichon JL; Fournier I; Fraquiero G; Gerbe J, 2016, 'Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: The ANRS 129 BKVIR trial', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 783 - 793, http://dx.doi.org/10.1093/jac/dkv384

Van Lunzen J; Antinori A; Cohen CJ; Arribas JR; Wohl DA; Rieger A; Rachlis A; Bloch M; Segal-Maurer S; Garner W; Porter D; Bosse M; Piontkowsky D; Chuck SK; De-Oertel S, 2016, 'Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: Week 96 efficacy and safety from a randomized phase 3b study', AIDS, vol. 30, pp. 251 - 259, http://dx.doi.org/10.1097/QAD.0000000000000911

Orkin C; Rjinders B; Stephan C; McKellar M; Kiertiburanakul S; Arribas J; Murphy D; Bloch M; Liu Y; Fordyce M; Yau S; McCallister S, 2016, 'P045 Switching from boosted atazanavir (ATV) plus FTC/TDF to a TAF-based single tablet regimen (STR): week 48 data in virologically suppressed adults', Sexually Transmitted Infections, vol. 92, pp. A34.1 - A34, http://dx.doi.org/10.1136/sextrans-2016-052718.99

Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J; Chene G; Sabin C; Walker S; Fisher M; Kelleher T; Cooper D; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Dabis F; Thiebaut R; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Hamouda O; Kucherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; De Luca A; Prins M; Geskus R; Van Der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Muga R; Tor J; De Olalla PG; Cayla J; Moreno S; Monge S; Del Romero J; Perez-Hoyos S; Sonnerborg A; Bucher HC; Gunthard H; Rickenbach M; Malyuta R; Murphy G; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Grarup J; Kirk O; Bailey H; Anne AV; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Sandhu M; Dedes N, 2015, 'Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?', AIDS, vol. 29, pp. 2323 - 2333, http://dx.doi.org/10.1097/QAD.0000000000000805

Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0139981

Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, vol. 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003

Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Allardice K; Baker D; Odgers E; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Ryder N; Taylor S; Cooper D; Carr A; Lee F; McRae K; Hesse K; Finlayson R; Gupta S; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Arvela N; Wray L; Thng C; Foster R; Lu H; Couldwell D; DSmith E; Furner V; Fernando S; Dubbo ; Watson J; Mulhall B; Wright S; Bendall C; Boyd M; Gunathilake M; Payne R; O'Sullivan M; White S; Russell D; Joslin J; Cashman C; Sowden D; Taing K; McGill K; Orth D; Youds D; Kelly M; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; N.Roth J; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K; Morwood K; Roth N; Choong K, 2015, 'Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)', BMC Infectious Diseases, vol. 15, http://dx.doi.org/10.1186/s12879-015-1051-4

Abgrall S; Rachas A; Tourret J; Isnard-Bagnis C; Billaud E; Tattevin P; Costagliola D; Guiguet M; Durieux P; Barin F; Billaud E; Boué F; Boyer L; Cabié A; Caby F; Canestri A; Costagliola D; Cotte L; De Truchis P; Duval X; Duvivier C; Enel P; Fischer H; Gasnault J; Gaud C; Gilquin J; Grabar S; Khuong MA; Launay O; Mahamat A; Mary-Krause M; Matheron S; Melica-Gregoire G; Melliez H; Meynard JL; Pavie J; Piroth L; Poizot-Martin I; Pradier C; Reynes J; Rouveix E; Simon A; Tattevin P; Tissot-Dupont H; Viard JP; Astier G; Martin D; Prade I; Jacquemet N; Abgrall S; Grabar S; Lang S; Lièvre L; Selinger-Leneman H; Lacombe JM; Potard V; Benveniste O; Simon A; Breton G; Lupin C; Bourzam E; Girard PM; Fonquernie L; Valin N; Lefebvre B; Sebire M; Pialoux G; Lebrette MG; Thibaut P; Adda A; Hamidi M; Cadranel J; Lavolé A; Parrot A; Oksenhendler E; Gerard L; Molina JM; Rozenbaum W; Denis B; De Castro N; Lascoux C; Bergmann JF; Delcey V; Lopes A; Sellier P; Parrinello M; Vignier N; Méchaï F; Makhloufi S; Honoré P; Yazdanpanah Y; Matheron S; Lariven S; Joly V; Rioux C; Khuong-Josses MA; Poupard M; Taverne B, 2015, 'A Multifaceted Intervention Designed to Improve Medical Management of Moderate to Advanced Chronic Kidney Disease in HIV-Infected Patients: A Cluster Randomized Trial', Clinical Infectious Diseases, vol. 61, pp. 375 - 384, http://dx.doi.org/10.1093/cid/civ310

Rockstroh JK; Nelson M; Katlama C; Lalezari J; Mallolas J; Bloch M; Matthews GV; Saag MS; Zamor PJ; Orkin C; Gress J; Klopfer S; Shaughnessy M; Wahl J; Nguyen BYT; Barr E; Platt HL; Robertson MN; Sulkowski M, 2015, 'Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, open-label trial', The Lancet HIV, vol. 2, pp. e319 - e327, http://dx.doi.org/10.1016/S2352-3018(15)00114-9

Lang S; Lacombe JM; Mary-Krause M; Partisani M; Bidegain F; Cotte L; Aslangul E; Chéret A; Boccara F; Meynard JL; Pradier C; Roger PM; Tattevin P; Costagliola D; Molina JM; Abgrall S; Barin F; Billaud E; Boué F; Boyer L; Cabié A; Caby F; Canestri A; Costagliola D; Cotte L; De Truchis P; Duval X; Duvivier C; Enel P; Fischer H; Gasnault J; Gaud C; Gilquin J; Grabar S; Khuong MA; Aunay OL; Mahamat A; Matheron S; Melica-Gregoire G; Melliez H; Meynard JL; Avie JP; Piroth L; Poizot-Martin I; Pradier C; Reynes J; Rouveix E; Simon A; Tattevin P; Tissot-Dupont H; Viard JP; Astier G; Martin D; Prade I; Jacquemet N; Costagliola D; Abgrall S; Rabar SG; Guiguet M; Lang S; Lièvre L; Selinger-Leneman H; Benveniste O; Simon A; Breton G; Lupin C; Bourzam E; Fonquernie L; Girard PM; Valin N; Lefebvre B; Sebire M; Pialoux G; Lebrette MG; Thibaut P; Adda A; Hamidi M; Cadranel J; Lavolé A; Parrot A; Lacombe JM; Potard V; Gerard L; Oksenhendler E; Rozenbaum W; Denis B; De Castro N; Lascoux C; Bergmann JF; Sellier P; Delcey V; Lopes A; Parrinello M; Bouchaud O; Vignier N; Méchaï F; Makhloufi S; Honoré P; Yazdanpanah Y, 2015, 'Is impact of statin therapy on all-cause mortality different in HIV-infected individuals compared to general population? Results from the FHDH-ANRS CO4 cohort', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0133358

Hoehn KB; Gall A; Bashford-Rogers R; Fidler SJ; Kaye S; Weber JN; McClure MO; Kellam P; Pybus OG; Breckenridge A; Clayden P; Conlon C; Conradie F; Kaldor J; Maggiolo F; Ssali F; Cooper DA; Kaleebu P; Ramjee G; Schechter M; Tambussi G; Weber J; Babiker A; Peto T; McLaren A; Beral V; Chene G; Hakim J; Porter K; Thomason M; Ewings F; Gabriel M; Johnson D; Thompson K; Cursley A; Donegan K; Fossey E; Kelleher P; Lee K; Murphy B; Nock D; Phillips R; Frater J; Ohm Laursen L; Robinson N; Goulder P; Brown H; McClure M; Bonsall D; Erlwein O; Helander A; Robinson M; Cook L; Adcock G; Ahmed P; Paton N; Fidler S; Kelleher A; Moore R; McFarlane R; Roth N; Finlayson R; Tee BK; Read T; Kelly M; Doong N; Bloch M; Workman C; Grey P; Cooper DA; Lawr M; Schechter M; Gama P; Mercon M; Barbosa de Souza M; Beppu Yoshida C; Grangeiro da Silva JR; Sampaio Amaral A; Fernandes de Aguiar D; de Fátima Melo M; Quaresma Garrido R; Tambussi G; Nozza S; Pogliaghi M; Chiappetta S; Della Torre L; Gasparotto E; D'Offizi G; Vlassi C; Corpolongo A; Wood R; Pitt J; Orrell C; Cilliers F; Croxford R, 2015, 'Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals', Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370, http://dx.doi.org/10.1098/rstb.2014.0241

Wright ST; Law MG; Cooper DA; Keen P; McDonald A; Middleton M; Woolley I; Kelly M; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Little JL; Smith D; Mincham C; Baker D; Ieroklis V; Templeton DJ; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Taylor S; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Patel A; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Fernando S; Chuah J; Watson J; Lawrence C; Mulhall B; McManus H; Bendall C; Boyd M; Ryder N; Payne R; Russell D; Doyle-Adams S; Sowden D; Taing K; McGill K; Orth D; Youds D; Gibson A; Magon H; Dickson B; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Giles M; Hoy J; Williams J; Nolan D; Robinson J; Morwood K; Roth N; Choong K; Li PCK; Lee MP; Vanar S; Faridah S; Kamarulzaman A; Choi JY; Vannary B; Ditangco R; Tsukada K; Pujari S; Makane A; Ng OT; Sasisopin AJ, 2015, 'Temporal trends of time to antiretroviral treatment initiation, interruption and modification: Examination of patients diagnosed with advanced HIV in Australia', Journal of the International AIDS Society, vol. 18, http://dx.doi.org/10.7448/IAS.18.1.19463

Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L; Allegre T; Livrozet JM; Jeanblanc F; Chiarello P; Makhloufi D; Trepo C; Peyramond D; Koffi J; Thoirain V; Brochier C; Baudry T; Pailhes S; Lafeuillade A; Allemand J; Danielli E; Philip G; Hittinger G; Assi A; Rieu A; Lambry V; Fuzibet JG; Cassuto JP; Quaranta M; Dellamonica P; Leplatois A; Naqvi A; Roger PM; Pujliese P; Durant J; Cua E; Vassallo M; Mondain-Miton V; Tempesta S; Ravaux I; Poizot Martin I; Champagne H; Pichancourt G; Morlat P; Bonnet F; Louis I; Aslan C; Malvy D; Lacoste D; Bernard N; Paccalin F; Bonarek M; Vandenhende MMA; Delaun J; Caltado S; Ragnaud JM; Dupont M; Dutronc H; Dauchy F; Cazenave C; Merlet A; Neau D; Pistone T; Blanchard E; Lacaze-Buz L; Pellegrin JL; Raymond I; Viallard JF; Lazaro E; Greib C; Wirth G; Chaigne De Lalande S; Saint Dizier F; Garipuy D; Obadia M; Chauveau M; Balzarin F; Reynes J; Baillat V; Merle C; Lemoing V; Atoui N; Makinson A; Jacquet JM; Psomas C; Villadero A; Tramoni C; Aumaitre H; Medus M; Malet M; Eden O; Neuville S; Ferreyra M; Cabie A; Abel S, 2015, 'Influence of lifelong cumulative HIV viremia on long-term recovery of CD4⁺ cell count and CD4⁺/CD8⁺ ratio among patients on combination antiretroviral therapy', AIDS, vol. 29, pp. 595 - 607, http://dx.doi.org/10.1097/QAD.0000000000000571

Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; Ellis D; Bloch M; Franic T; Agrawal S; McCann L; Cunningham N; Vincent T; Allen D; Little JL; Smith D; Gray C; Baker D; Vale R; Templeton DJ; Dijanosic C; Jackson E; McCallum K; Taylor S; Cooper D; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Shakeshaft J; Brown K; McGrath C; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Watson J; Lawrence C; Mulhall B; Law M; Petoumenos K; McManus H; Bendall C; Boyd M; Kulatunga A; Knibbs P; Chuah J; Ngieng M; Dickson B; Russell D; Downing S; Sowden D; Broom J; Taing K; Johnston C; McGill K; Orth D; Youds D; Kelly M; Gibson A; Magon H; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Nicolson J; Lau H; Read T; Silvers J; Zeng W; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Skett J; Robinson J; Mean CV; Saphonn V; Vohith K; Zhang FJ; Li PCK; Lee MP; Kumarasamy N; Saghayam S; Ezhilarasi C; Pujari S, 2015, 'HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD)', HIV Medicine, vol. 16, pp. 152 - 160, http://dx.doi.org/10.1111/hiv.12188

Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, vol. 12, http://dx.doi.org/10.1371/journal.pmed.1001809

Connor D; Greaves I; Porter K; Bloch M, 2015, 'Prehospital spinal immobilisation: An initial consensus statement', Trauma, vol. 17, pp. 146 - 150, http://dx.doi.org/10.1177/1460408614556441

Scott I; Porter K; Laird C; Greaves I; Bloch M, 2015, 'The prehospital management of pelvic fractures: Initial consensus statement', Trauma, vol. 17, pp. 151 - 154, http://dx.doi.org/10.1177/1460408614556442

Rockstroh JK; Nelson M; Katlama C; Lalezari J; Mallolas J; Bloch M; Matthews G; Saag M; Zamor P; Orkin C; Gress J; Klopfer S; Platt H; Robertson M; Sulkowski M, 2015, 'P0887 : C-edge co-infected: phase 3 study of grazoprevir/elbasvir in patients with HCV/HIV', Journal of Hepatology, vol. 62, pp. S675 - S675, http://dx.doi.org/10.1016/s0168-8278(15)31089-8

Russo M; de Looze F; Bloch M; Montgomery B; Smith G; Shephard A; Aspley S, 2015, '(366) Efficacy of flurbiprofen 8.75 mg spray in patients with relatively severe sore throat symptoms', The Journal of Pain, vol. 16, pp. S67 - S67, http://dx.doi.org/10.1016/j.jpain.2015.01.285

Cohen C; Wohl D; Arribas JR; Henry K; Van Lunzen J; Bloch M; Towner W; Wilkins E; Ebrahimi R; Porter D; White K; Walker I; Chuck S; De-Oertel S; Fralich T, 2014, 'Week 48 results from a randomized clinical trial of rilpivirine/ emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/ tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults', AIDS, vol. 28, pp. 989 - 997, http://dx.doi.org/10.1097/QAD.0000000000000169

Kamara DA; Ryom L; Ross M; Kirk O; Reiss P; Morlat P; Moranne O; Fux CA; Mocroft A; Sabin C; Lundgren JD; Smith CJ; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Ryom L; Sabin CA; Smith C; Phillips A; Mocroft A; Tverland J; Mansfeld M; Nielsen J; Raben D; Lundgren JD; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Ryom L; Mocroft A; Kirk O; Reiss P; Ross M; Morlat P; Kesselring AM; Smith C; Lundgren JD; Smith C; Ryom L; Phillips A; Weber R; Morlat P; Pradier C; Reiss P; Friis-Møller N; Kowalska J; Lundgren JD; Sabin C; Law M; D'Arminio Monforte A; Dabis F; Bruyand M; Reiss P; Smith C; Bower M; Fätkenheuer G; Donald A; Grulich A; Ryom L; Lundgren JD; Zaheri S; Gras L; Prins JM; Kuijpers TW; Scherpbier HJ; Van Der Meer JTM; Wit FWMN; Godfried MH; Reiss P; Van Der Poll T; Nellen FJB; Lange JMA; Geerlings SE; Van Vugt M; Pajkrt D; Bos JC; Van Der Valk M, 2014, 'Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study', BMC Nephrology, vol. 15, http://dx.doi.org/10.1186/1471-2369-15-51

Bloch M; Tong W; Hoy J; Baker D; Lee F; Richardson R; Carr A, 2014, 'Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks', HIV Medicine, vol. 15, pp. 373 - 380, http://dx.doi.org/10.1111/hiv.12123

Bieber T; Chosidow O; Bodsworth N; Tyring S; Hercogova J; Bloch M; Davis M; Lewis M; Boutolleau D; Attali P; Bisshop FR; Bloch MT; Bodworth NJ; Aster V; Asterova J; Klimesova R; Krajsova I; Ben Slama L; Cambazard F; Dubertret L; Granel F; Humbert P; Ortonne JP; Rostain G; Ruer-Mulard M; Vaillant L; Beiber T; Degen AJ; Dörzapf O; Von Hake G; Miller A; Naudts I; Steinert M; Stockfleth E; Weihe J; Wunderlich U; Jasieniak-Pinis G; Kazina M; Pawlaczyk-Strugala E; Placek W; Petryka R; Romanowski L; Dixon CJ; Lewis M; Sharma R; Archuleta M; Baker DA; Cady RK; Conant MA; Crump WL; Davis MG; Dunlap FE; Lee PC; McCarthy FT; Tyring SK, 2014, 'Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP trial): A double-blind, placebo-controlled, self-initiated trial', Journal of Drugs in Dermatology, vol. 13, pp. 791 - 798

Curtis L; Nichols G; Stainsby C; Lim J; Aylott A; Wynne B; Clark A; Bloch M; Maechler G; Martin-Carpenter L; Raffi F; Min S, 2014, 'Dolutegravir: Clinical and laboratory safety in integrase inhibitor-naive patients', HIV Clinical Trials, vol. 15, pp. 199 - 208, http://dx.doi.org/10.1310/hct1505-199

Patterson C; Shakeel M; Ram B; Bloch M, 2014, 'Retrograde intubation in a patient with stridor: An old technique revisited', Journal of the College of Physicians and Surgeons Pakistan, vol. 24, pp. 449

Bloch M; Jayewardene A; Vincent T; Linton N; Quan D; Gowers A, 2014, 'Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy.', J Int AIDS Soc, vol. 17, pp. 19546, http://dx.doi.org/10.7448/IAS.17.4.19546

Cordel H; Cailhol J; Matheron S; Bloch M; Godineau N; Consigny PH; Gros H; Campa P; Bourée P; Fain O; Ralaimazava P; Bouchaud O, 2013, 'Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: A prospective observational study of 553 cases', Malaria Journal, vol. 12, http://dx.doi.org/10.1186/1475-2875-12-399

Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; Wit SD; Phillips A; Lundgren JD; Sabin CA; Butcher D; Delforge M; Fanti I; Franquet X; Geffard S; Gras L; Helweg-Larsen J; Hillebregt M; Kamara D; Kjær J; Krum E; McManus H; Meidahl P; Mocroft A; Nielsen J; Powderl W; Rickenbach M; Rode R; Ryom L; Salbøl Brandt R; Schmidt Iversen J; Shortman N; Sjøl A; Smith C; Torres F; Tverland J; Wright S; Zaheri S; de Wolf F; Smidt J; Ristola M; Katlama C; Viard JP; Girard PM; Livrozet JM; Vanhems P; Pradier C; Dabis F; Neau D; Rockstroh J; Schmidt R; Degen O; van Lunzen J; Stellbrink HJ; Staszewski S; Bogner J; Gargalianos P; Kosmidis J; Perdios J; Xylomenos G; Filandras A; Karabatsaki E; Panos G; Sambatakou H; Banhegyi D; Mulcahy F; Burke M; Turner D; Yust I; Hassoun G; Pollack S; Maayan S; Vella S; Esposito R; Mazeu I; Mussini C; Arici C; Pristera R; Gabbuti A; Mazzotta F; Lichtner M; Vullo V; Boer K; Geerlings SE; Godfried MH; Kuijpers TW; Lange JMA; Nellen FJB; Pajkrt D; Prins JM; Scherpbier HJ; Vrouenraets SME; Wit FWMN; van Vugt M, 2013, 'Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study', BMC Infectious Diseases, vol. 13, http://dx.doi.org/10.1186/1471-2334-13-471

Booth SM; Bloch M, 2013, 'An evaluation of a new prehospital pre-alert guidance tool', Emergency Medicine Journal, vol. 30, pp. 820 - 823, http://dx.doi.org/10.1136/emermed-2012-201545

Cohen C; Wohl D; Arribas J; Henry K; Bloch M; Towner W; Ebrahimi R; Porter D; De-oertel S; Quercia R; Fralich T, 2013, 'STAR: Rilpivirine/Emtricitabine/TenofovirDF is non-inferior to Efavirenz/Emtricitabine/TenofovirDF in naive adult Latino, black & white subpopulations', Journal of the International AIDS Society, vol. 16, http://dx.doi.org/10.7448/ias.16.2.18683

Russo M; Bloch M; Looze FD; Morris C; Shephard A, 2013, 'Flurbiprofen microgranules for relief of sore throat: A randomised, double-blind trial', British Journal of General Practice, vol. 63, http://dx.doi.org/10.3399/bjgp13X663118

Nelson MR; Elion RA; Cohen CJ; Mills A; Hodder SL; Segal-Maurer S; Bloch M; Garner W; Guyer B; Williams S; Chuck S; Vanveggel S; Deckx H; Stevens M, 2013, 'Rilpivirine versus efavirenz in hiv-1-infected subjects receiving emtricitabine/tenofovir df: Pooled 96-week data from ECHO and THRIVE studies', HIV Clinical Trials, vol. 14, pp. 81 - 91, http://dx.doi.org/10.1310/hct1403-81

Raffi F; Rachlis A; Stellbrink HJ; Hardy WD; Torti C; Orkin C; Bloch M; Podzamczer D; Pokrovsky V; Pulido F; Almond S; Margolis D; Brennan C; Min S, 2013, 'Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study', The Lancet, vol. 381, pp. 735 - 743, http://dx.doi.org/10.1016/S0140-6736(12)61853-4

Smith AH; Laird C; Porter K; Bloch M, 2013, 'Haemostatic dressings in prehospital care.', Emergency medicine journal : EMJ, vol. 30, pp. 784 - 789, http://dx.doi.org/10.1136/emermed-2012-201581

Leenders FJ; Amin J; Bloch M; Pett SL; Marriott D; Carr AD, 2013, 'Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 62, pp. 525 - 533, http://dx.doi.org/10.1097/QAI.0b013e3182832578

Cohen C; Wohl D; Arribas J; Henry K; Lunzen JV; Bloch M; Towner W; Wilkins E; Wang H; White K; Poulin Porter D; Guyer B; Fralich T, 2012, 'STAR Study: single tablet regimen emtricitabine/rilpivirine/tenofovir DF is non-inferior to efavirenz/emtricitabine/tenofovir DF in ART-naïve adults', Journal of the International AIDS Society, vol. 15, http://dx.doi.org/10.7448/ias.15.6.18221

Schlesinger N; Alten RE; Bardin T; Schumacher HR; Bloch M; Gimona A; Krammer G; Murphy V; Richard D; So AK, 2012, 'Canakinumab for acute gouty arthritis in patients with limited treatment options: Results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions', Annals of the Rheumatic Diseases, vol. 71, pp. 1839 - 1848, http://dx.doi.org/10.1136/annrheumdis-2011-200908

Nelson M; Amaya G; Clumeck N; Arns da cunha C; Jayaweera D; Junod P; Li T; Tebas P; Stevens M; Buelens A; Vanveggel S; Boven K; Abusamra L; Cahn P; Laplume HE; Cassetti I; Ceriotto M; Martins MD; Krolewiecki A; Amarilis Lugo L; Bolan R; Bush L; Corales R; Crane L; De Vente J; Fischl M; Gathe J; Greenberg R; Henry K; Jayaweera D; Kumar P; Lalezari J; Leider J; Lubelchek R; Martorell C; Mounzer K; Cohen C; Olivet H; Ortiz R; Rhame F; Roberts A; Ruane P; Scribner A; Segal-Maurer S; Short W; Sloan L; Wilkin T; Wohlfeiler M; Yangco B; Bloch M; Gold J; Hoy J; Martinez P; Baker D; Finlayson R; Roth N; Rieger A; Vetter N; Zangerle R; Da Cunha CA; Grinsztejn B; Madruga JV; Pilotto JH; Sampaio D; Gonsalez CR; Lima MP; Rangel F; Timerman A; Kilby D; Rachlis A; Walmsley S; Boissonnault M; Brunetta J; De Wet J; Gill J; Kasper K; Macleod J; Gerstoft J; Mathiesen L; Pedersen C; Cotte L; Girard PM; Molina JM; Raffi F; Vittecoq D; Yazdanpanah Y; Yeni P; Boue F; Katlama C; Reynes J; Fisher M; Nelson M; Orkin C; Taylor S; Johnson M; Wilkins E; Williams IG; Winston A; Lazzarin A, 2012, 'Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials', Journal of Antimicrobial Chemotherapy, vol. 67, pp. 2020 - 2028, http://dx.doi.org/10.1093/jac/dks130

Twiss J; McKenna SP; Bloch M; Bonney M, 2012, 'Erratum: Patient and clinician perceived benefit of early consumption of famciclovir for the treatment of herpes outbreaks. Value in Health (2011) 14:7 (A266))', Value in Health, vol. 15, pp. 789, http://dx.doi.org/10.1016/j.jval.2012.07.001

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, vol. 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, vol. 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377

Koelsch KK, 2012, 'No significant effect of uridine or pravastatin treatment for HIV lip atrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomised trial.', HIV Medicine, vol. 11, pp. 493 - 501, http://dx.doi.org/10.1111/j.1468-1293.2009.00817.x

Carey DL; Pett SL; Bloch M; Wand H; MacRae K; Beileiter K; Ray J; Boyd MA; Emery S; Cooper DA, 2012, 'A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 60, pp. 143 - 149, http://dx.doi.org/10.1097/QAI.0b013e318252f97e

Twiss J; Mckenna S; Bloch M; Bonney MA, 2011, 'PIN5 Patient and Clinician Perceived Benefit of Early Consumption of Famciclovir for the Treatment of Herpes Outbreaks', Value in Health, vol. 14, pp. A266 - A266, http://dx.doi.org/10.1016/j.jval.2011.08.193

Amin J; Martin A; Bloch M; Carr A, 2010, 'Reply to Landman and Soonawala', Clinical Infectious Diseases, vol. 50, pp. 1200 - 1201, http://dx.doi.org/10.1086/651469

Bloch M; Farris M; Tilden D; Gowers A; Cunningham N, 2010, 'Triple-class HIV antiretroviral therapy failure in an Australian primary care setting', Sexual Health, vol. 7, pp. 17 - 24, http://dx.doi.org/10.1071/SH09039

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, vol. 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Bloch M; Hoy J; Cunningham N; Roth N; Andrianopoulos N; Rayner C; Carr A, 2010, 'Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia', Journal of the International AIDS Society, vol. 13, pp. P172 - P172, http://dx.doi.org/10.1186/1758-2652-13-s4-p172

Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P; Fraqueiro RL; Fraqueiro G; Pauchard CK; Pauchard M; Fontaine C; Michon C; Bensalem M; Perre P; Suaud I; Molina JM; Rachline A; Goujard C; Môle M; Arvieux C; Ratajczak M; Touam MB; Touam F; Girard PM; Lagneau JL; Raffi F; Hue H; Zucman D; de Truchis P; Berthe H; Levy Y; Jung C; Piketty C; Reynes J; Vidal M; Sereni D; Bloch M, 2009, 'Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: The 2IP ANRS 127 study', Journal of Antimicrobial Chemotherapy, vol. 64, pp. 118 - 125, http://dx.doi.org/10.1093/jac/dkp146

Meads DM; McKenna SP; Bonney MA; Bloch MT, 2009, 'Further validation and responsiveness assessment of the herpes outbreak impact questionnaire and herpes symptom checklist', Value in Health, vol. 12, pp. 397 - 400, http://dx.doi.org/10.1111/j.1524-4733.2008.00450.x

Martin A; Bloch MT; Amin J; Baker DL; Cooper DA; Emery S; Carr AD, 2009, 'Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial', Clinical Infectious Diseases, vol. 49, pp. 1591 - 1601, http://dx.doi.org/10.1086/644769

Mitsuyasu RT; Merigan T; Carr AD; Zack J; Winters M; Workman C; Bloch MT; Lalezari J; Becker S; Thornton L; Akil B; Khanlou H; Finlayson R; Mcfarlane R; Smith DE; Garsia R; Ma DD; Law MG; Murray JM; Von Kalle C; Ely JA; Patino S; Knop A; Wong P; Todd A; Haughton M; Fuery C; Marcpherson J; Symonds G; Evans L; Pond SM; Cooper DA, 2009, 'Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells', Nature Medicine, vol. 15, pp. 285 - 292, http://dx.doi.org/10.1038/nm.1932

Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J; Abdurahman I; Ajam A; Alexander R; Aung A; Barry S; Becker B; Belbin M; Bishop C; Bisshop F; Bourne C; Brett T; Brown K; Butler A; Carmody C; Chan D; Chuah J; Conway D; Daly C; Davies S; Davis C; Davis B; Dever N; Donovan B; Eisen D; Eliades C; Elisha B; Fairley C; Feiglin A; Freeman A; Furner V; Garland S; Genn W; Giannakopoulos J; Glass F; Gold J; Goswami J; Gowers A; Grech J; Hackney P; Hanson B; Hartnell K; Harvey C; Hasan M; Hawkins S; Heley S; Herbst D; Hespe C; Irlicht M; Isaacs A; Katahanas L; Kelly M; Komarowski P; Kostic G; Kozminsky M; Lagios K; Lee D; Lewis P; Liang T; Lyttle H; Mackellar-Michelmore H; Macleod H; Marsh L; Marshall L; McCloskey J; McCurdy D; McEvoy P; McFarlane R; McKeegan P; McMurchie M; McNamee K; Medland N; Menon A; Meyerowitz C; Michaels W; Mobbs M; Montague A; Nicola N; Nurcombe C; O'Connor C; Ooi C; Ostrowskyl O; O'Sullivan M; Owen L; Papp K; Patten J; Panopoulous D; Pell C; Philpot R; Quan D; Quin J; Rhodes D, 2008, '2-Day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study (Sexual Health (2008) 5, 3, (219-225))', Sexual Health, vol. 5, pp. 379, http://dx.doi.org/10.1071/SH08013_CO

Bodsworth NJ; Bloch MT; Mcnulty A; Denham I; Doong N; Trottier S; Adena MA; Bonney M; Agnew J; Australo-Canadian Fast A, 2008, '2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study', Sexual Health, vol. 5, pp. 219 - 225, http://dx.doi.org/10.1071/SH08013

Monforte A; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law MG; de Witt S; Friis-Moller N; Phillips AN; Sabin C; Lundgren JD, 2008, 'HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.', AIDS, vol. 22, pp. 2143 - 2153, http://dx.doi.org/10.1097/QAD.0b013e3283112b77

Sabin C; Monforte A; Friis-Moller N; Weber R; El-Sadr W; Reiss P; Kirk O; Mercie P; Law MG; De Wit S; Pradier C; Phillips A; Lundgren JD, 2008, 'Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction', Clinical Infectious Diseases, vol. 46, pp. 1101 - 1110, http://dx.doi.org/10.1086/528862

Markowitz M; Nguyen BY; Gotuzzo E; Mendo F; Ratanasuwan W; Kovacs C; Prada G; Morales-Ramirez JO; Crumpacker CS; Isaacs RD; Gilde LR; Wan H; Miller MD; Wenning LA; Teppler H; Baker D; Bloch M; Bodsworth N; Cooper D; Workman C; Kovacs C; Tsoukas C; Afani A; Perez J; Cortes J; Thitivichianlert S; Brown S; Crumpacker C; Galpin J; Hicks C; Kumar P; Lichtenstein K; Little S; Liporace R; Santana-Bagur J; Schwartz R; Steigbigel R; Tashima K, 2007, 'Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: Results of a 48-week controlled study', Journal of Acquired Immune Deficiency Syndromes, vol. 46, pp. 125 - 133, http://dx.doi.org/10.1097/QAI.0b013e318157131c

Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, vol. 8, pp. 112 - 123, http://dx.doi.org/10.1111/j.1468-1293.2007.00440.x

Lowy M; Collins S; Bloch M; Gillman M; Lording D; Sutherland P; Wang H; Stecher V, 2007, 'Quality of erection questionnaire correlates: Change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunction', Journal of Sexual Medicine, vol. 4, pp. 83 - 92, http://dx.doi.org/10.1111/j.1743-6109.2006.00398.x

Emery S; Kelleher AD; Workman C; Puls R; Bloch MT; Baker D; Hoy JF; Ip S; Nalliah K; Ward L; Law MG; Cooper DA, 2007, 'Influence of IFN gamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy', Human Vaccines, vol. 3, pp. 260 - 267, http://dx.doi.org/10.4161/hv.4627

Collins S; Mertenskoetter T; Loeliger E; Tressler R; Weller I; Friis-Møller N; Worm SW; Sabin CA; Sjøl A; Lundgren JD; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Weber R; Reisswafaamel-Sadr P; Kirk O; Dabis F; Law MG; Pradier C; De Wit S; Akerlund B; Calvo G; Monforte ADA; Ledergerber B; Phillips AN; De Wolf F; Zaheri S; Bronsveld W; Hillebrand-Haverkort ME; Prins JM; Bos JC; Schattenkerk JKME; Geerlings SE; Godfried MH; Lange JMA; Van Leth FC; Lowe SH; Van Der Meer JTM; Nellen FJB; Pogány K; Van Der Poll T; Reiss P; Ruys TA; Sankatsing SU; Steingrover R; Van Twillert G; Van Der Valk M; Van Vonderen MGA; Vrouenraets SME; Van Vugt MV; Wit FWMN; Van Eeden A; Ten Veen JH; Van Dam PS; Roos JC; Brinkman K; Frissen PHJ; Weigel HM; Mulder JW; Van Gorp ECM; Meenhorst PL; Mairuhu ATA; Veenstra J; Danner SA; Van Agtmael MA; Claessen FAP; Perenboom RM; Rijkeboer A; Richter C; Van Der Berg J; Van Leusen R; Vriesendorp R; Jeurissen FJF; Kauffmann RH; Koger ELW; Bravenboer B; Ten Napel CHH; Kootstra GJ; Sprenger HG; Miesen WMAJ; Doedens R; Scholvinck EH; Ten Kate RW; Van Houte DPF; Polee M; Kroon FP; Van Den Broek PJ; Van Dissel JT; Schippers EF; Schreij G; Van De Geest S, 2006, 'Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study', Archives of Internal Medicine, vol. 166, pp. 1632 - 1641, http://dx.doi.org/10.1001/archinte.166.15.1632

Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TBP; Helmyr PME; Silva de Mendonça J; Carvalho LHF; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA, 2006, 'Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting', HIV Medicine, vol. 7, pp. 146 - 155, http://dx.doi.org/10.1111/j.1468-1293.2006.00358.x

Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, vol. 7, pp. 70 - 85, http://dx.doi.org/10.1310/4733-ACQF-F3P4-2QAC

Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 42, pp. 192 - 202, http://dx.doi.org/10.1097/01.qai.0000219779.50668.e6

Kinloch-De Loes S; Hoen B; Smith DE; Autran B; Lampe FC; Phillips AN; Goh LE; Andersson J; Tsoukas C; Sonnerborg A; Tambussi G; Girard PM; Bloch M; Battegay M; Carter N; El Habib R; Theofan G; Cooper DA; Perrin L, 2005, 'Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection', Journal of Infectious Diseases, vol. 192, pp. 607 - 617, http://dx.doi.org/10.1086/432002

Chee CC; Mortier E; Dupont C; Bloch M; Simonpoli AM; Rouveix E, 2005, 'Medical and social differences between French and migrant patients consulting for the first time for HIV infection', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, vol. 17, pp. 516 - 520, http://dx.doi.org/10.1080/09540120412331291760

Winston A; Bloch MT; Carr AD; Amin J; Mallon PW; Ray J; Marriott D; Cooper DA; Emery S, 2005, 'Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy', Journal of Antimicrobial Chemotherapy, vol. 56, pp. 380 - 387, http://dx.doi.org/10.1093/jac/dki235

Ray J; Marriott D; Bloch MT; McLachlan AJ, 2005, 'Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic', British Journal of Clinical Pharmacology, vol. 60, pp. 291 - 299, http://dx.doi.org/10.1111/j.1365-2125.2005.02413.x

Van Leth F; Phanuphak P; Stroes E; Gazzard B; Cahn P; Raffi F; Wood R; Bloch M; Katlama C; Kastelein JJP; Schechter M; Murphy RL; Horban A; Hall DB; Lange JMA; Reiss P, 2004, 'Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1', PLoS Medicine, vol. 1, pp. 064 - 074, http://dx.doi.org/10.1371/journal.pmed.0010019

Martin A; Smith DE; Carr AD; Hoy JF; Chuah J; Mallal SA; Law MG; Clements MS; Cooper DA, 2004, 'Progression of lipodystrophy (LD) with continued thymidine analogue usage: Long-term follow-up from a randomized clinical trial (the PIILR study)', HIV Clinical Trials, vol. 5, pp. 192 - 200, http://dx.doi.org/10.1310/0GU7-6X27-MMHE-5ALE

Mortier E; Toure S; Seyler C; Bloch M; Anglaret X, 2003, 'Urinary pH in HIV-infected adults in Ivory Coast and in France [3]', AIDS, vol. 17, pp. 2003 - 2005, http://dx.doi.org/10.1097/00002030-200309050-00028

Levy Y; Durier C; Krzysiek R; Rabian C; Capitant C; Lascaux AS; Michon C; Oksenhendler E; Weiss L; Gastaut JA; Goujard C; Rouzioux C; Maral J; Delfraissy JF; Emilie D; Aboulker JP; Gougeon ML; Metro A; Viard JP; Bouchenafa K; Jung C; Mortier E; Bloch M; Chandemerle C; Gérard L; Martinie M; Kazatchkine M; Laureillard D; Dinh TT; Dalmas AM; Peretti D; Rannou MT; Bazin C; Verdon R; Six M; Goubin P; Vittecoq D; Escaut L; Malet M; Maignan A; Bouvet E; Prevot MH; Fournier I; Gaudebout C; Yéni P; Belarbi L; Mandet C; Zucman D; Majerholc C; Boue F; Estocq GA; Delavalle AM; Pasquali JL; Lalanne H; Bouchet-Delbos L; Chambenoit C; Carmagnat MV; Grangeot-Keros L; Ameisen JC; Estaquier J; Monnier D; Ferchal F; Girard PM; Laplanche A; Bazin B; Foubert V; Izard S; Martins J; Netzer E, 2003, 'Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: A randomized controlled trial', AIDS, vol. 17, pp. 343 - 351, http://dx.doi.org/10.1097/00002030-200302140-00008

Kaufmann GR; Bloch MT; Finlayson RJ; Zaunders J; Smith DE; Cooper DA, 2002, 'The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy', AIDS, vol. 16, pp. 359 - 367, http://dx.doi.org/10.1097/00002030-200202150-00007

Bloch M, 2001, 'Current tren HIV therapy', Current Therapeutics, vol. 42, pp. 8 - 12

Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R; International Panretin Gel KS Study Group , 2001, 'Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.', Am J Clin Dermatol, vol. 2, pp. 77 - 87, http://dx.doi.org/10.2165/00128071-200102020-00004

Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, vol. 11, pp. 1833 - 1838, http://dx.doi.org/10.1097/00002030-199715000-00007

Bloch MW; Smith DA; Nelson DL, 1989, 'Heart rate, activity, duration, and affect in added-purpose versus single-purpose jumping activities.', The American journal of occupational therapy. : official publication of the American Occupational Therapy Association, vol. 43, pp. 25 - 30, http://dx.doi.org/10.5014/ajot.43.1.25

Michon C; Facy F; Boue F; Henry S; Bloch M, 1993, 'Evaluation of the medical follow-up in drug addicts with HIV infection. Report and preliminary results of a multicentric study in Ile-de-France', in Revue d'Epidemiologie et de Sante Publique